USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cathay Industrial Biotech Ltd.

USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cathay ranks #28,353 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 6 technology areas.

#28,353
of 49,997 US assignees by volume
16th percentile
by Innovation Score (24.9/100)
13.9
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28353 · Foreign Corporation #28,353 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,353/49,997
  • PHOTO-FINISH Casa Systems
  • CPC-NARROW C07C · 6 areas
  • INNOV-THIN 24.9/100
  • CLAIMS-RICH 13.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Casa Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cathay’s 24.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cathay

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cathay's Innovation Score is 24.9/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cathay?

Each dot is one of Cathay’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cathay’s own 13.9 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cathay vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 051015202530 Granted patents (volume) Avg claims / patent Casa Systems, Inc. - 9, 20.22Casa SystemsCaseConcept, LLC - 9, 4.33CaseconceptCaso Holding GmbH - 9, 4.33Caso HoldingCatalytic Distillation Technologies - 9, 16.22Catalytic Distill…Cavagna Group S.P.A. - 9, 18.67Cavagna Group S P…Cedar Ridge Research LLC - 9, 19.11Cedar Ridge Resea…Celanese EVA Performance Polymers LLC - 9, 26.56Celanese EVA Perf…Celcuity Inc. - 9, 15.78CelcuityCathay Industrial Biotech Ltd. - 9, 13.89Cathay Industrial…
Cathay vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cathay's grants concentrate

Cathay Industrial Biotech Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 88.9% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2019. By volume, Cathay sits between Casa Systems, Inc. and Celcuity Inc..

Who files at Cathay's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cathay holds 9 patents at rank #28,435, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cathay

By rank, the assignees closest to #28,435 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Cathay's primary technology class.

Cathay's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2016201720182019 1
USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Cathay Industrial Biotech Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 22.2%
2017 3 33.3%
2018 3 33.3%
2019 1 11.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cathay Industrial Biotech Ltd.'s patent record in context - here's where to go next.

  • Cathay Industrial Biotech Ltd.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 88.9% of its portfolio - see every assignee active in that class. Explore C07C
  • Ranked #28,353 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cathay Industrial Biotech Ltd. against Casa Systems, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.